These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 3185697)
1. Conflict of interest over Harvard drug. Shulman S Nature; 1988 Oct; 335(6193):754. PubMed ID: 3185697 [No Abstract] [Full Text] [Related]
2. Ocular surface keratinization as a predictor of response to topical retinoic acid therapy. Herbort CP; Weissman SS; Ostler HB; Cevallos A; Char DH Arch Ophthalmol; 1989 Sep; 107(9):1275-6. PubMed ID: 2476978 [No Abstract] [Full Text] [Related]
3. Successful use of topical retinoic acid in severe dry eye due to chronic graft-versus-host disease. Murphy PT; Sivakumaran M; Fahy G; Hutchinson RM Bone Marrow Transplant; 1996 Sep; 18(3):641-2. PubMed ID: 8879631 [TBL] [Abstract][Full Text] [Related]
4. Corneal calcification in dry eye disorders associated with retinoic acid therapy. Avisar R; Deutsch D; Savir H Am J Ophthalmol; 1988 Dec; 106(6):753-5. PubMed ID: 3195663 [No Abstract] [Full Text] [Related]
6. Effects of three kinds of topical eye-drops on the experimental rabbit dry eye. Xie HP; Zhang HC Chin Med J (Engl); 1993 Mar; 106(3):196-201. PubMed ID: 8325144 [TBL] [Abstract][Full Text] [Related]
7. Management of evaporative dry eye in ectrodactyly-ectodermal dysplasia-clefting syndrome. Ota Y; Matsumoto Y; Dogru M; Goto E; Uchino Y; Endo K; Tsubota K Optom Vis Sci; 2008 Sep; 85(9):E795-801. PubMed ID: 18772710 [TBL] [Abstract][Full Text] [Related]
8. The scientific context and basis of the pharmacologic management of dry eyes. Gilbard JP Ophthalmol Clin North Am; 2005 Dec; 18(4):475-84, v. PubMed ID: 16314213 [TBL] [Abstract][Full Text] [Related]
9. New ocular therapeutics: a view from the patenting perspective. Mucke HA IDrugs; 2007 Jan; 10(1):37-41. PubMed ID: 17187313 [TBL] [Abstract][Full Text] [Related]
10. Considerations in the pharmacoeconomics of dry eye. Hirsch JD Manag Care; 2003 Dec; 12(12 Suppl):33-8. PubMed ID: 14723112 [TBL] [Abstract][Full Text] [Related]
11. [Dry eye syndrome: is there any hope for a curative therapy?]. Calonge M Arch Soc Esp Oftalmol; 2002 Mar; 77(3):119-20. PubMed ID: 11967731 [No Abstract] [Full Text] [Related]
12. [Nucleotides: new therapeutic approach for dry eye treatment]. Assumpta Peral DO Arch Soc Esp Oftalmol; 2004 Jan; 79(1):3-4. PubMed ID: 14752694 [No Abstract] [Full Text] [Related]
13. Dry eye symptoms following cataract surgery. Roberts CW; Elie ER Insight; 2007; 32(1):14-21; quiz 22-3. PubMed ID: 17533782 [TBL] [Abstract][Full Text] [Related]
14. Successful tear lipid layer treatment for refractory dry eye in office workers by low-dose lipid application on the full-length eyelid margin. Goto E; Dogru M; Fukagawa K; Uchino M; Matsumoto Y; Saiki M; Tsubota K Am J Ophthalmol; 2006 Aug; 142(2):264-70. PubMed ID: 16876507 [TBL] [Abstract][Full Text] [Related]
15. Issues in the use of preservative-free topicals. Perry HD; Donnenfeld ED Manag Care; 2003 Dec; 12(12 Suppl):39-41. PubMed ID: 14723113 [TBL] [Abstract][Full Text] [Related]
16. Integrating restasis into the management of dry eye. Pflugfelder SC Int Ophthalmol Clin; 2006; 46(4):101-3. PubMed ID: 17060796 [No Abstract] [Full Text] [Related]